Carl Sailer V.'s Insider Trades & SAST Disclosures
Carl Sailer V.'s most recent trade in Acurx Pharmaceuticals Inc was a trade of 24,631 Common Stock done at an average price of $1.0 . Disclosure was reported to the exchange on Jan. 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carl Sailer V..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acurx Pharmaceuticals Inc | Carl V. Sailer | Director | Purchase of securities on an exchange or from another person at price $ 1.01 per share. | 06 Jan 2025 | 24,631 | 137,183 | - | 1.0 | 25,000 | Common Stock |
| Acurx Pharmaceuticals Inc | Carl V. Sailer | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 06 Jan 2025 | 24,631 | 24,631 | - | - | Warrants for Common Stock | |
| Acurx Pharmaceuticals Inc | Carl V. Sailer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 12,000 | 12,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | Sailer V. Carl | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2024 | 19,737 | 0 | - | - | Warrants for Common Stock | |
| Acurx Pharmaceuticals Inc | Carl Sailer V. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.55 per share. | 19 Jan 2024 | 19,737 | 112,552 | - | 3.5 | 70,066 | Common Stock |
| Acurx Pharmaceuticals Inc | Carl V. Sailer | Director | Purchase of securities on an exchange or from another person at price $ 4.84 per share. | 23 Nov 2021 | 5,161 | 73,078 | - | 4.8 | 24,979 | Common Stock |
| Acurx Pharmaceuticals Inc | Carl V. Sailer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 50,000 | 50,000 | - | - | Stock Option | |
| Acurx Pharmaceuticals Inc | Carl V. Sailer | Director | Purchase of securities on an exchange or from another person at price $ 6.00 per share. | 29 Jun 2021 | 12,500 | 67,917 | - | 6 | 75,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges